Key result
Ethmozine was superior to disopyramide in achieving near-total abolition of ventricular premature depolarizations and was well tolerated without significant side effects.
RCT (n=27)
Double-blind
Answers are grounded in this paper and cite their sources.
Ethmozine may be preferred over disopyramide for ventricular premature depolarization suppression; extends randomized comparative efficacy data for Class I agents.
This placebo-controlled, double-blind, longitudinal crossover study compares the efficacy of disopyramide and ethmozine, a new investigational drug, in suppressing frequent (40 or more per hour) ventricular premature depolarizations (VPDs) in 27 patients completing a 37 day protocol. Although both drugs significantly reduced VPDs relative to placebo, ethmozine was a superior antiarrhythmic drug in ach9eving near-total abolition of VPDs (30% of patients), which was never observed during disopyramide dosing (p less than .05). At the 80% VPD reduction level, ethmozine was effective in 56% of all patients compared with an effectiveness in only 22% of patients during disopyramide therapy (p less than .05). The mean peak plasma level of ethmozine was 0.66 +/- 0.8 micrograms/ml, which significantly fell to a trough level of 0.1 +/- 0.08 micrograms/ml (p less than .001). Mean peak and trough plasma levels of disopyramide exhibited less fluctuation (2.6 +/- 0.9 micrograms/ml vs 2.2 +/- 0.9 micrograms/ml). Ethmozine had no effect on the QT interval, whereas disopyramide prolonged it significantly. Importantly, while disopyramide produced serious side effects in 30% of patients, ethmozine was well tolerated with no statistically significant side effects compared with placebo.
No takes yet. Share an insight, caveat, or question.
Pratt et al. (1984) conducted an RCT in Frequent ventricular premature depolarizations (VPDs) (n=27). Ethmozine vs. Disopyramide and placebo was evaluated on Near-total abolition of ventricular premature depolarizations (VPDs) (p=<0.05). Ethmozine was superior to disopyramide in achieving near-total abolition of ventricular premature depolarizations and was well tolerated without significant side effects.
Synapse has enriched 10 related papers. Consider them for comparative context: